Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
1.105
+0.074 (7.18%)
Aug 10, 2026, 10:47 AM EDT - Market open
Immuron Market Cap
Immuron has a market cap or net worth of $7.61 million as of August 10, 2026. Its market cap has decreased by -18.14% in one year.
Market Cap
7.61M
Enterprise Value
697.90K
1-Year Change
-18.14%
Ranking
Category
Stock Price
$1.11
ChartMarket Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $7.61M, a decrease of -72.91%. That is a compound annual growth rate of -13.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 8.40M | 86.67% |
| Dec 31, 2025 | 4.50M | -53.61% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Curis | 7.83M |
| Bolt Biotherapeutics | 7.78M |
| MetaVia | 7.69M |
| Ensysce Biosciences | 7.64M |
| Can-Fite BioPharma | 7.57M |
| BioVie | 7.54M |
| Niki BioSolutions | 7.32M |
| AEON Biopharma | 7.29M |